𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anaesthesia for lung volume reduction surgery

✍ Scribed by J. Hillier; C. Gillbe


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
174 KB
Volume
58
Category
Article
ISSN
0003-2409

No coin nor oath required. For personal study only.

✦ Synopsis


Summary

Lung volume reduction surgery is a surgical treatment for severe emphysema that is increasing in popularity. The aim is to reverse the hyperexpansion of the lungs that leads to expiratory airflow limitation, compromises the diaphragm and chest wall mechanics, and tamponades the right ventricle. Optimal patient selection has not yet been established, but it has become clear that those patients with the most severe disease have an unacceptably high surgical mortality. The anaesthetic management of patients undergoing lung volume reduction surgery requires a good understanding of both the pathophysiology of the disease and the surgical procedure. It is important for the anaesthetist and the surgeon to work closely, supported by a large multidisciplinary team. Excellent analgesia is essential to a successful outcome; whether this is best provided by thoracic epidural is as yet unclear.


πŸ“œ SIMILAR VOLUMES


Anaesthesia for Vascular Surgery
✍ D. G. Thomas πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 70 KB
Chest radiographic findings following vi
✍ Costello, Philip ;Petrucco, Michael πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 120 KB

Surgical reduction of lung volume is being investigated as a promising alternative in the treatment of selected patients with severe debilitating emphysema. Following bilateral video‐assisted thoracoscopic surgical resection (VATS) of emphysematous lung tissue, patients show improvements in exercise

Reductive surgery of unresectable lung c
✍ H. Takita πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 152 KB

The only effective therapy for non-small-cell lung cancers has been surgical resection. In the present study a patient with unresectable adenocarcinoma of the lung was treated by chemoimmunotherapy and surgery, and has been doing well for 19 months following surgery. The case is presented as an exam